Six of these reported cases were detected in outpatient settings among individuals with no known CRE risk factors like overnight hospital stays, dialysis treatment, surgery within the past year or invasive device exposure within the previous two days.
The CRE detected in the 10 Colorado patients contained the New Delhi metallo-β-lactamase enzyme, which makes the bacteria resistant to a broad range of antibiotics. This particular strain of CRE is uncommon in the U.S. and considered to be a global threat.
“The finding that 6 of 10 recent NDM-producing CRE are community-associated suggests that the epidemiology of CRE could be changing. Further surveillance is required to determine whether this pattern continues,” wrote the study’s authors.
More articles on infection control:
Arkansas mumps outbreak continues, cases hit 2,200
Top 10 infection control stories, Dec. 12-16
National Park Service looks to expand infectious disease surveillance
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.